Frontlight ResearchEarly access
Trial site
Multiprofile Hospital for Active Treatment - Dobrich AD
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Obesity4 trials
- Chronic kidney disease3 trials
- Lung cancer3 trials
- Ulcerative colitis2 trials
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Metastatic breast cancer1 trial
- Peripheral artery disease1 trial
- Prostate cancer1 trial
- Psoriasis1 trial
- Rheumatoid arthritis1 trial
- and 1 more
- Phase
- Phase 313 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Completed7 trials
- Recruiting5 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Pfizer2 trials
- Amgen1 trial
- Boehringer Ingelheim1 trial
- CSL Behring1 trial
- Debiopharm International SA1 trial
- and 10 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Recruiting
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026